A Post Hoc Analysis of Statin Use in Tolvaptan Autosomal Dominant Polycystic Kidney Disease Pivotal Trials

Por Shoaf, Susan E., Ouyang, John, Sergeyeva, Olga, Estilo, Alvin, Li, Hui, Leung, Deborah
Publicado no Clin J Am Soc Nephrol (2020)

The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations

Por Perrone, Ronald D., Chapman, Arlene B., Oberdhan, Dorothee, Czerwiec, Frank S., Sergeyeva, Olga, Ouyang, John, Shoaf, Susan E.
Publicado no Kidney Int Rep (2020)

A Randomized Trial of Modified-Release Versus Immediate-Release Tolvaptan in ADPKD

Por Perrone, Ronald D., Chapman, Arlene B., Oberdhan, Dorothee, Czerwiec, Frank S., Sergeyeva, Olga, Ouyang, John, Shoaf, Susan E.
Publicado no Kidney Int Rep (2020)

Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease

Por Torres, Vicente E., Devuyst, Olivier, Chapman, Arlene B., Gansevoort, Ron T., Perrone, Ronald D., Ouyang, John, Blais, Jaime D., Czerwiec, Frank S., Sergeyeva, Olga
Publicado no Am J Nephrol (2017)

Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

Por Torres, Vicente E., Chapman, Arlene B., Devuyst, Olivier, Gansevoort, Ron T., Perrone, Ronald D., Lee, Jennifer, Hoke, Molly E., Estilo, Alvin, Sergeyeva, Olga
Publicado no Clin J Am Soc Nephrol (2021)